BQU57
CAS No. 1637739-82-2
BQU57 ( BQU57 | BQU 57 | BQU-57 )
产品货号. M17354 CAS No. 1637739-82-2
BQU57 相对于 Ras 或 Rho 表现出对 Ral 的选择性抑制,并抑制异种移植肿瘤生长。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ¥187 | 有现货 |
|
| 5MG | ¥309 | 有现货 |
|
| 10MG | ¥531 | 有现货 |
|
| 25MG | ¥798 | 有现货 |
|
| 50MG | ¥1107 | 有现货 |
|
| 100MG | ¥2007 | 有现货 |
|
| 200MG | ¥2862 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥341 | 有现货 |
|
生物学信息
-
产品名称BQU57
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述BQU57 相对于 Ras 或 Rho 表现出对 Ral 的选择性抑制,并抑制异种移植肿瘤生长。
-
产品描述BQU57 is a GTPase Ral inhibitor. The Ras-like GTPases RalA and RalB are important drivers of tumour growth and metastasis. Chemicals that block Ral function would be valuable as research tools and for cancer therapeutics. The binding of the RBC8 derivative BQU57 to RalB was confirmed by isothermal titration calorimetry, surface plasmon resonance and (1)H-(15)N transverse relaxation-optimized spectroscopy (TROSY) NMR spectroscopy. RBC8 and BQU57 show selectivity for Ral relative to the GTPases Ras and RhoA and inhibit tumour xenograft growth to a similar extent to the depletion of Ral using RNA interference. The utility of structure-based discovery for the development of therapeutics for Ral-dependent cancers.
-
体外实验——
-
体内实验——
-
同义词BQU57 | BQU 57 | BQU-57
-
通路Angiogenesis
-
靶点CDK
-
受体Ral
-
研究领域Cancer
-
适应症——
化学信息
-
CAS Number1637739-82-2
-
分子量334.3
-
分子式C16H13F3N4O
-
纯度>98% (HPLC)
-
溶解度DMSO : ≥ 36 mg/mL; 107.69 mM
-
SMILESCc1nn(c2c1C(C(=C(O2)N)C#N)c1ccc(cc1)C(F)(F)F)C
-
化学全称6-amino-1,3-dimethyl-4-(4-(trifluoromethyl)phenyl)-1,4-dihydropyrano[2,3-c]pyrazole-5-carbonitrile
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Yan C, et al. Nature. 2014 Nov 20; 515(7527): 443-447.
021-51111890
购物车()
sales@molnova.cn

